Zobrazeno 1 - 10
of 479
pro vyhledávání: '"R D, Carvajal"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-5 (2019)
Abstract Background Eosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events. Case presentation We rep
Externí odkaz:
https://doaj.org/article/b989977539fe4b47916491fc5bca37e4
Autor:
S. Piperno-Neumann, M. S. Carlino, V. Boni, D. Loirat, F. M. Speetjens, J. J. Park, E. Calvo, R. D. Carvajal, M. Nyakas, J. Gonzalez-Maffe, X. Zhu, M. D. Shirley, T. Ramkumar, A. Fessehatsion, H. E. Burks, P. Yerramilli-Rao, E. Kapiteijn
Publikováno v:
British Journal of Cancer, 128, 1040-1051. SPRINGERNATURE
Background Up to 50% of patients with uveal melanoma develop metastases (MUM) with a poor prognosis and median overall survival of approximately 1 year. Methods This phase I study evaluated the safety, tolerability, pharmacokinetics, pharmacodynamics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc13a7b6997fe71f8832691ca2f3966f
http://hdl.handle.net/1887/3566795
http://hdl.handle.net/1887/3566795
Autor:
F, Dimitriou, K, Namikawa, I L M, Reijers, E I, Buchbinder, J A, Soon, A, Zaremba, P, Teterycz, M J, Mooradian, E, Armstrong, Y, Nakamura, M G, Vitale, L E, Tran, X, Bai, C, Allayous, S, Provent-Roy, A, Indini, P, Bhave, M, Farid, K C, Kähler, I, Mehmi, V, Atkinson, O, Klein, C J, Stonesifer, F, Zaman, A, Haydon, R D, Carvajal, O, Hamid, R, Dummer, A, Hauschild, M S, Carlino, M, Mandala, C, Robert, C, Lebbe, J, Guo, D B, Johnson, P A, Ascierto, A N, Shoushtari, R J, Sullivan, B, Cybulska-Stopa, P, Rutkowski, L, Zimmer, S, Sandhu, C U, Blank, S N, Lo, A M, Menzies, G V, Long
Mucosal melanoma (MM) is a rare melanoma subtype with distinct biology and poor prognosis. Data on the efficacy of immune checkpoint inhibitors (ICIs) are limited. We determined the efficacy of ICIs in MM, analyzed by primary site and ethnicity/race.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc56111b83de57d0e398a5cc2f06c3a3
https://www.ncbi.nlm.nih.gov/pubmed/35716907
https://www.ncbi.nlm.nih.gov/pubmed/35716907
Publikováno v:
Sarcoma, Vol 2015 (2015)
Externí odkaz:
https://doaj.org/article/749392d6d05044cfac256e6c00cd77d7
Publikováno v:
Sarcoma, Vol 2014 (2014)
Sarcomas are heterogeneous malignant tumors of mesenchymal origin characterized by more than 100 distinct subtypes. Unfortunately, 25–50% of patients treated with initial curative intent will develop metastatic disease. In the metastatic setting, c
Externí odkaz:
https://doaj.org/article/f4d00a735ecc46b48a05f16cddde7b90
Autor:
Ouyang S; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China., Shi S; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China., Ding W; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China., Ge Y; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China., Su Y; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, China., Mo J; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China., Peng K; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China., Zhang Q; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China., Liu G; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, China., Xiao W; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, China., Yue P; Department of Medicine, Division of Hematology-Oncology, and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Lu J; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China., Wang Y; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, China., Xiong X; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China., Zhang X; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
Publikováno v:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Oct 18, pp. e2407967. Date of Electronic Publication: 2024 Oct 18.
Autor:
Seedor RS; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Aplin AE; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Bertolotto C; INSERM, Paris, France., Carvajal RD; Northwell Health Cancer Institute, New Hyde Park, New York, USA., Deacon N; Patient Advocate, British Columbia, Canada., Doble K; Patient Advocate, Denver, Colorado, USA., Hamid O; The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, Los Angeles, California, USA., Haq R; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kadosh M; Melanoma Research Foundation, CURE OM, Washington, DC, USA., Khan S; Northwell Health Cancer Institute, New Hyde Park, New York, USA., Kraska J; Melanoma Research Foundation, CURE OM, Washington, DC, USA., Lutzky J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., McKean M; Sarah Cannon Research Institute, Nashville, Tennessee, USA., Montazeri K; Mass General Cancer Center, Boston, Massachusetts, USA., Moser J; HonorHealth Research Institute, Scottsdale, Arizona, USA., Onken M; Washington University in St. Louis, St. Louis, Missouri, USA., Orloff M; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Sacco JJ; Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK., Smalley K; Moffitt Cancer Center, Tampa, Florida, USA., Selig SM; Melanoma Research Foundation, CURE OM, Washington, DC, USA.
Publikováno v:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2024 Oct 09. Date of Electronic Publication: 2024 Oct 09.
Autor:
Ren, Hong1, Wu, Zhenkai2,3, Tan, Jia4,5, Tao, Hui1, Zou, Wangyuan6, Cao, Zheng7, Wen, Binyu1, Cai, Ziyi1, Du, Jiaqi1, Deng, Zhihong1 602073@csu.edu.cn
Publikováno v:
Advanced Science. 8/21/2024, Vol. 11 Issue 31, p1-12. 12p.
Autor:
Liang, Xiuqi1 (AUTHOR), Li, Xinchao1 (AUTHOR), Wu, Rui1 (AUTHOR), He, Tao1 (AUTHOR), Liu, Furong1 (AUTHOR), Li, Lu1 (AUTHOR), Zhang, Yi2 (AUTHOR), Gong, Songlin1 (AUTHOR), Zhang, Miaomiao1 (AUTHOR), Kou, Xiaorong1 (AUTHOR), Chen, Tao1 (AUTHOR), You, Yanjie3 (AUTHOR), Shen, Meiling1 (AUTHOR), Wu, Qinjie1 (AUTHOR), Gong, Changyang1 (AUTHOR) gongchangyang@scu.edu.cn
Publikováno v:
Advanced Science. 7/24/2024, Vol. 11 Issue 28, p1-14. 14p.
Autor:
Yao, Yiran1,2 (AUTHOR), Xu, Ru3 (AUTHOR), Shao, Weihuan1,2 (AUTHOR), Tan, Ji3 (AUTHOR) tanji@mail.sic.ac.cn, Wang, Shaoyun1,2 (AUTHOR), Chen, Shuhan3 (AUTHOR), Zhuang, Ai1,2 (AUTHOR) aizhuang@sjtu.edu.cn, Liu, Xuanyong3 (AUTHOR) xyliu@mail.sic.ac.cn, Jia, Renbing1,2 (AUTHOR) renbingjia@sjtu.edu.cn
Publikováno v:
Advanced Science. 7/10/2024, Vol. 11 Issue 26, p1-13. 13p.